(FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | 335.00%69.07M | ---- | 86.61%-29.39M | ---- | -217.72%-219.46M | ---- | 77.14%-69.08M | ---- | -35.43%-302.19M | ---- |
Profit adjustment | ||||||||||
Interest (income) - adjustment | -68.28%-244K | ---- | -25.00%-145K | ---- | -792.31%-116K | ---- | 99.31%-13K | ---- | 14.49%-1.88M | ---- |
Interest expense - adjustment | -42.18%27.07M | ---- | 6.04%46.81M | ---- | -20.81%44.15M | ---- | 59.63%55.75M | ---- | 35.32%34.92M | ---- |
Attributable subsidiary (profit) loss | 12.84%21.96M | ---- | -78.03%19.46M | ---- | 1,253.89%88.56M | ---- | -90.43%6.54M | ---- | 1,537.00%68.32M | ---- |
Impairment and provisions: | 11,977.64%60.51M | --0 | -99.64%501K | --0 | 1,082.57%137.99M | --0 | -83.14%11.67M | --0 | -45.26%69.21M | --0 |
-Impairmen of inventory (reversal) | -962.33%-1.26M | ---- | --146K | ---- | ---- | ---- | -90.05%2.61M | ---- | 2,994.11%26.27M | ---- |
-Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | -112.19%-1.1M | ---- | 223.97%9.06M | ---- | -28.61%2.8M | ---- |
-Other impairments and provisions | 17,299.44%61.77M | ---- | -99.74%355K | ---- | --139.1M | ---- | ---- | ---- | -67.00%40.14M | ---- |
Revaluation surplus: | 71.24%-4.13M | --0 | -742.81%-14.35M | --0 | 368.13%2.23M | --0 | -81.38%477K | --0 | --2.56M | --0 |
-Fair value of investment properties (increase) | 151.64%989K | ---- | ---1.92M | ---- | ---- | ---- | -81.38%477K | ---- | --2.56M | ---- |
-Derivative financial instruments fair value (increase) | ---- | ---- | ---- | ---- | ---121K | ---- | ---- | ---- | ---- | ---- |
-Other fair value changes | 58.86%-5.12M | ---- | -628.42%-12.44M | ---- | --2.35M | ---- | ---- | ---- | ---- | ---- |
Asset sale loss (gain): | ---589K | --0 | --0 | --0 | 3,275.00%540K | --0 | 100.06%16K | --0 | -2,524.52%-26.79M | --0 |
-Loss (gain) from sale of subsidiary company | ---589K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---27.09M | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | 3,275.00%540K | ---- | -94.59%16K | ---- | -73.21%296K | ---- |
Depreciation and amortization: | -54.38%15.74M | --0 | 18.38%34.5M | --0 | 251.98%29.14M | --0 | -19.81%8.28M | --0 | 38.52%10.33M | --0 |
-Depreciation | 2.87%12.95M | ---- | 21.33%12.59M | ---- | 25.48%10.38M | ---- | -19.82%8.27M | ---- | 38.58%10.31M | ---- |
-Amortization of intangible assets | -87.27%2.79M | ---- | 16.75%21.91M | ---- | 170,518.18%18.77M | ---- | -8.33%11K | ---- | 0.00%12K | ---- |
Special items | -27,251.69%-120.28M | ---- | 100.63%443K | ---- | -158.77%-69.89M | ---- | -124.09%-27.01M | ---- | --112.12M | ---- |
Operating profit before the change of operating capital | 19.51%69.11M | --0 | 339.83%57.83M | --0 | 198.35%13.15M | --0 | 59.99%-13.37M | --0 | 51.80%-33.41M | --0 |
Change of operating capital | ||||||||||
Inventory (increase) decrease | 59.46%-14.43M | ---- | -1,354.70%-35.58M | ---- | -127.94%-2.45M | ---- | 388.23%8.75M | ---- | 143.25%1.79M | ---- |
Accounts receivable (increase)decrease | 94.07%-1.29M | ---- | -162.23%-21.74M | ---- | 230.71%34.93M | ---- | -893.73%-26.73M | ---- | 124.76%3.37M | ---- |
Accounts payable increase (decrease) | 113.42%11.54M | ---- | -177.88%-85.98M | ---- | 1,294.22%110.41M | ---- | -738.03%-9.25M | ---- | -97.73%1.45M | ---- |
prepayments (increase)decrease | 56.89%-14.85M | ---- | -43.40%-34.45M | ---- | -23.28%-24.02M | ---- | -1,019.06%-19.48M | ---- | 105.83%2.12M | ---- |
Cash from business operations | 140.03%50.08M | --0 | -194.77%-125.12M | --0 | 319.78%132.02M | --0 | -143.38%-60.07M | --0 | 58.61%-24.68M | --0 |
Other taxs | 26.44%-11.07M | ---- | -280.46%-15.06M | ---- | -208.42%-3.96M | ---- | -264.49%-1.28M | ---- | -169.84%-352K | ---- |
Interest paid - operating | -75.62%-11.46M | ---- | -1,145.61%-6.53M | ---- | 60.95%-524K | ---- | -22.22%-1.34M | ---- | ---1.1M | ---- |
Special items of business | ---- | ---- | ---5.2M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net cash from operations | 118.78%27.54M | 75.58%-33.86M | -215.03%-146.7M | -381.62%-138.65M | 303.43%127.54M | -140.18%-28.79M | -139.92%-62.69M | 83.45%-11.99M | 55.80%-26.13M | -46.39%-72.43M |
Cash flow from investment activities | ||||||||||
Interest received - investment | 68.28%244K | ---- | 25.00%145K | ---- | 792.31%116K | ---- | 30.00%13K | ---- | 25.00%10K | ---- |
Purchase of fixed assets | -5,207.67%-17.3M | ---- | 51.63%-326K | ---- | -36.71%-674K | ---- | 86.85%-493K | ---- | -85.54%-3.75M | ---- |
Purchase of intangible assets | ---- | ---- | ---2.45M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --18.07M | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | --31.03M | ---- | ---- | ---- | ---- | ---- |
Net cash from investment operations | -549.62%-17.06M | 63.64%-4K | -108.62%-2.63M | -100.04%-11K | 6,447.92%30.47M | 3,675.97%25.75M | -103.35%-480K | 99.66%-720K | 48.91%14.34M | -2,130.99%-210.68M |
Net cash before financing | 107.02%10.48M | 75.58%-33.87M | -194.51%-149.33M | -4,459.68%-138.66M | 350.12%158.01M | 76.07%-3.04M | -435.63%-63.17M | 95.51%-12.71M | 76.17%-11.79M | -623.95%-283.11M |
Cash flow from financing activities | ||||||||||
New borrowing | 56.65%21.88M | ---- | -67.70%13.97M | ---- | -42.44%43.24M | ---- | 104.28%75.13M | ---- | -35.23%36.78M | ---- |
Refund | 56.27%-9.56M | ---- | 32.72%-21.85M | ---- | -32.90%-32.48M | ---- | 3.86%-24.44M | ---- | -31.38%-25.42M | ---- |
Issuing shares | ---- | ---- | 364.79%139.44M | ---- | 47.20%30M | ---- | --20.38M | ---- | ---- | ---- |
Absorb investment income | ---- | ---- | ---- | ---- | --208K | ---- | ---- | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | 93.95%-5.19M | ---- | -398.23%-85.8M | ---- | -563.62%-17.22M | ---- | ---2.6M | ---- | ---- | ---- |
Other items of the financing business | 36.12%-1.49M | ---- | -10.20%-2.33M | ---- | 1.35%-2.12M | ---- | 8.01%-2.15M | ---- | -110.64%-2.33M | ---- |
Net cash from financing operations | -86.99%5.65M | -26.05%14.15M | 100.70%43.42M | -44.82%19.13M | -67.39%21.63M | 286.30%34.67M | 635.09%66.33M | -96.67%8.98M | -77.66%9.02M | 1,594.69%269.24M |
Effect of rate | -186.17%-3.32M | -126.33%-13.9M | 2,354.39%3.86M | -10,489.66%-6.14M | -489.66%-171K | 76.23%-58K | 94.51%-29K | -24.49%-244K | 20.24%-528K | 81.97%-196K |
Net Cash | 115.23%16.13M | 83.50%-19.72M | -158.96%-105.91M | -477.91%-119.53M | 5,593.79%179.64M | 947.74%31.63M | 213.86%3.16M | 73.11%-3.73M | 69.55%-2.77M | 40.25%-13.87M |
Begining period cash | -50.75%99.06M | -50.75%99.06M | 829.14%201.11M | 829.14%201.11M | 16.88%21.65M | 16.88%21.65M | -15.12%18.52M | -15.12%18.52M | -30.91%21.82M | -30.91%21.82M |
Cash at the end | 12.93%111.87M | -13.26%65.44M | -50.75%99.06M | 41.77%75.44M | 829.14%201.11M | 265.90%53.22M | 16.88%21.65M | 87.71%14.54M | -15.12%18.52M | 6.50%7.75M |
Cash balance analysis | ||||||||||
Cash and cash equivalent balance | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Qualified opinion | -- | Qualified opinion | -- |
Auditor | Hwashin Certified Public Accountants Co., Ltd. | -- | Hwashin Certified Public Accountants Co., Ltd. | -- | Hwashin Certified Public Accountants Co., Ltd. | -- | Hwashin Certified Public Accountants Co., Ltd. | -- | Hwashin Certified Public Accountants Co., Ltd. | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data